Effects of changes in adipocyte hormones and visceral adipose tissue and the reduction of obesity-related comorbidities after laparoscopic sleeve gastrectomy in Japanese patients with severe obesity

Endocrine Journal

Volumn 61, Issue 4, 2014, Pages 381-391

  Umemura, Akira ^a   Sasaki, Akira ^a   Nitta, Hiroyuki ^a   Otsuka, Koki ^a   Suto, Takayuki ^b   Wakabayashi, Go ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Morioka Municipal Hospital   (Japan)

Author keywords

Adiponectin; Bariatric surgery; Laparoscopic sleeve gastrectomy; Leptin; Type 2 diabetes mellitus

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; SERPINE1 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INTRAABDOMINAL FAT; JAPANESE (PEOPLE); LAPAROSCOPIC SURGERY; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SLEEVE GASTRECTOMY; THERAPY EFFECT; BLOOD; BODY MASS; CELL CULTURE; COMPLICATION; DIET THERAPY; FOLLOW UP; GASTROPLASTY; INSULIN RESISTANCE; JAPAN; LAPAROSCOPY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OBESITY, MORBID; PATHOLOGY; SECRETION (PROCESS); WEIGHT REDUCTION;

ADIPOKINES; ADIPOSITY; ADULT; BODY MASS INDEX; CELLS, CULTURED; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JAPAN; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84899695577     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0524     Document Type: Article

References (37)

1. Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23: 427-436.
2. Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patients. Obes Surg 13: 861-864.
3. Kueper MA, Kramer KM, Kirschniak A, Königsrainer A, Pointner R, et al. (2008) Laparoscopic sleeve gastrectomy: standardized technique of a potential standalone bariatric procedure in morbidly obese patients. World J Surg 32: 1462-1465.
4. Nguyen NT, Nguyen B, Gebhart A, Hohmann S (2013) Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg 216: 252-257.
5. Sasaki A, Wakabayashi G, Yonei Y (2013) Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol doi: 10.1007/s00535-013-0802-5
6. Himpens J, Dapri G, Cadière GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16: 1450-1456.
7. Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, et al. (2011) First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 254: 410-420.
8. Chen J, Pamuklar Z, Spagnoli A, Torquati A (2012) Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc 26: 1476-1480.
9. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451.
10. Carroll JF, Franks SF, Smith AB, Phelps DR (2009) Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study. Obes Surg 19: 47-55.
11. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106: 473-481.
12. Arner P (2005) Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19: 471-482.
13. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, et al. (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366: 1577-1585.
14. Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, et al. (2013) GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg 257: 894-899.
15. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, et al. (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146: 143-148.
16. Kasama K, Tagaya N, Kanehira E, Oshiro T, Seki Y, et al. (2009) Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg 19: 1341-1345.
17. Dixon JB, Zimmet P, Alberti KG, Rubino F: International Diabetes Federation Taskforce on Epidemiology and Prevention (2011) Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 28: 628-642.
18. Sugihara H, Yonemitsu N, Miyabara S, Yun K (1986) Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation 31: 42-49.
19. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, et al. (2009) How do we define cure of diabetes? Daibetes Care 32: 2133-2135.
20. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, et al. (2011) Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377: 557-567.
21. Flegal KM, Carroll MD, Kit BK, Oqden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
22. Choo V (2002) WHO reassesses appropriate body-mass index for Asian populations. Lancet 360: 235.
23. Bracale R, Labruna G, Finelli C, Daniele A, Sacchetti L, et al. (2012) The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance. J Endocrinol Invest 35: 2-4.
24. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ouedrani A, et al. (2012) Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers. Genet Test Mol Biomarkers 16: 726-733.
25. Suter M, Donadini A, Romy S, Demartines N, Giusti V (2011) Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesityrelated comorbidities and quality of life. Ann Surg 254: 267-273.
26. Kasama K, Tagaya N, Kanahira E, Umezawa A, Kurosaki T, et al. (2008) Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon. Obes Surg 18: 1473-1478.
27. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, et al. (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15: 1024-1029.
28. Boza C, Salinas J, Salgado N, Pérez G, Raddatz A, et al. (2012) Laparoscopic sleeve gastrectomy as a standalone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg 22: 866-871.
29. Chopra A, Chao E, Etkin Y, Merklinger L, Lieb J, et al. (2012) Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure? Surg Endosc 26: 831-837.
30. Koshy AA, Bobe AM, Brady MJ (2013) Potential mechanisms by which bariatric surgery improves systemic metabolism. Transl Res 161: 63-72.
31. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247: 401-407.
32. Vestergaard ET, Djurhuus CB, Gjedsted J, Nielsen S, Møller N, et al. (2008) Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab 93: 438-444.
33. Zhang N, Maffei A, Cerabona T, Pahuja A, Omana J, et al. (2013) Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc 27: 1273-1280.
34. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, et al. (2011) First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 25: 3540-3550.
35. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, et al. (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366: 1567-1576.
36. Sutherland K, Lee RW, Phillips CL, Dungan G, Yee BJ, et al. (2011) Effect of weight loss on upper airway size and facial fat in men with obstructive sleep apnea. Thorax 66: 797-803.
37. Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, et al. (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122: 829-839.